Medicine guide
MYSIMBA
As listed in the register: MYSIMBA 8 MG/90 MG COMPRIMIDOS DE LIBERACION PROLONGADA
8 - REVISAR mg · comprimido de liberación prolongada
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Naltrexona + bupropion
- Made by
- Orexigen Therapeutics Ireland Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupDigestion, stomach, diabetes and nutritionA08AA62
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Orexigen Therapeutics Ireland Limited |
|---|---|
| Active substance | Naltrexona + bupropion |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 8 - REVISAR mg |
| Form | comprimido de liberación prolongada |
| Classification | A08AA62 · Digestion, stomach, diabetes and nutrition |
| Route | vía oral |
| Marketed | No — authorised but not currently marketed, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | MYSIMBA 8 MG/90 MG COMPRIMIDOS DE LIBERACION PROLONGADA |
| Nº Registro | 114988001 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.